Humoral immune responses against facultative pathogen Candida utilis in atopic patients with vulvovaginal candidiasis. Candida utilis glucomannan – New serologic biomarker

• Published in: Immunobiology (1979) Vol. 227; no. 1; p. 152154
• Main Authors: Paulovičová, E., Hrubiško, M.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier GmbH 01.01.2022
• Subjects: Antiglycan antibodies; Biomarkers; Candida; Candida albicans; Candida utilis; Candidiasis, Vulvovaginal - diagnosis; Female; Glucomannan; Humans; Immunity, Humoral; Immunoglobulin A; Immunoglobulin M; Mannans; Saccharomyces cerevisiae; Vulvovaginal candidiasis; Vulvovaginal candidiasis; Candida utilis; Antiglycan antibodies; Glucomannan

[Display omitted] Vulvovaginal candidiasis is one of the most commonly reported female genital tract infections, affecting approximately 70–75% of childbearing age women at least once during their lifetime. Approximately 50% of patients have refractory episodes and in 5–10% of cases the disease has...